About Bioline  All Journals  Testimonials  Membership  News

Indian Journal of Pharmacology
Medknow Publications on behalf of Indian Pharmacological Society
ISSN: 0253-7613
EISSN: 0253-7613
Vol. 36, No. 1, 2004, pp. 25-28
Bioline Code: ph04007
Full paper language: English
Document type: Research Article
Document available free of charge

Indian Journal of Pharmacology, Vol. 36, No. 1, 2004, pp. 25-28

 en Single oral dose toxicity study of α-cypermethrin in rats
S. Manna, D. Bhattacharyya, D. K. Basak, T. K. Mandal


Objective: To evaluate the acute effect of α-cypermethrin (α-CP) on antioxidant activities, oxidants, biochemical and histopathological changes at LD50 dose level.
Material and Methods: α-CP at single LD50 (145 mg/kg) dose was administered orally to Wistar rats while controls received an equal volume of the vehicle, DMSO. The antioxidants, oxidants, biochemical and histopathological changes in some visceral organs were studied following α-CP.
Results: A single LD50 dose of α-CP increased the malondialdehyde (MDA) level and decreased the activities of catalase (CAT), superoxide dismutase (SOD) and glycogen in the liver. It also increased the serum aminotransaminases (AST, ALT), alkaline phosphatase (ALP), and lactate dehydrogenase (LDH) activities, and blood glucose level. It produced some cytotoxic effect on the lungs, liver, stomach, intestine, testes and cerebellum. The vehicle DMSO may have influenced the determination of LD50 of α-CP in rats.
Conclusion: A single, oral LD50 dose of α-CP decreased antioxidant status, and altered biochemical parameters, which correlated with histopathological changes in rats.

Acute toxicity, insecticide, pyrethroid

© Copyright 2004 - Medknow Publications on behalf of the Indian Pharmacological Society. Also available online at
Alternative site location:

Home Faq Resources Email Bioline
© Bioline International, 1989 - 2024, Site last up-dated on 01-Sep-2022.
Site created and maintained by the Reference Center on Environmental Information, CRIA, Brazil
System hosted by the Google Cloud Platform, GCP, Brazil